TD Cowen Downgrades Milestone Pharmaceuticals (MIST) to Hold
Tweet Send to a Friend
TD Cowen analyst Ritu Baral downgraded Milestone Pharmaceuticals (NASDAQ: MIST) from Buy to Hold.The analyst comments "We are downgrading MIST ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
